Highly Effective Tumor Detection Strategy for Common Childhood Brain Tumors
Texas A&M University | October22nd,2020
Study reveals potential epigenetic biomarker in cerebrospinal fluid of pediatric medulloblastoma
Latest
Technology Shines the Light on Ovarian Cancer Treatments
Purdue University | October22nd,2020
Light scattering technique helps personalize chemotherapy treatments
How Labs Can Bolster Antimicrobial Stewardship
Anne Beall | October22nd,2020
COVID-19 has emphasized the importance of rapid results from the laboratory
Rutgers Finds New Way to Personalize Treatments for Prostate Cancer
Rutgers University | October21st,2020
Researchers uncovered new protein markers that could help predict risk of metastasis
Patients with Severe COVID-19 May Be the Best Donors for Convalescent Plasma Therapy
Johns Hopkins University Bloomberg School of Public Health | October21st,2020
Study links stronger antibody responses to more severe disease, as well as more advanced age and male sex
Changes in Blood Metabolite Profile Are Visible Years before Diagnosis of Alcohol-Related Disease
University of Eastern Finland | October20th,2020
The finding opens up new avenues for preventing alcohol-related adverse effects
Cannabidiol Helps Reduce Lung Damage from COVID by Increasing Levels of Protective Peptide
Medical College of Georgia at Augusta University | October20th,2020
Cannabidiol quickly increases levels of apelin, a natural peptide known to reduce inflammation
Multi-Omics Adds New Cell to Immune Family Tree
Walter and Eliza Hall Institute | October19th,2020
Powerful single cell multi-omics technologies discover ancestor of T and B lymphocytes
New Technology Diagnoses Sickle Cell Disease in Record Time
University of Colorado Boulder | October19th,2020
The test only requires a small drop of blood to assess protein interactions, dysfunction, or mutations.
The Native Antigen Company Launches Range of SARS-CoV-2 Specific Antibodies
The Native Antigen Company | October16th,2020
These 10 antibodies recognize different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-specific and do not cross-react with other human coronaviruses